Select Publications
Conference Abstracts
2022, 'Rates of somatic variants in homologous recombination DNA repair deficiency genes in older patients with high-grade serous ovarian carcinoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000879941200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 Genes Based on Ovarian Tumor Pathology Characteristics', in GENETIC EPIDEMIOLOGY, WILEY, Vol. 46, pp. 520 - 521, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000850044000128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Abstract 2248: Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. 2248 - 2248, http://dx.doi.org/10.1158/1538-7445.am2022-2248
,2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 208, http://dx.doi.org/10.4049/jimmunol.208.Supp.179.04
,2022, 'Use of ovarian cancer tumour pathology characteristics to aid classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 genes', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, Vol. 30, pp. 418 - 419, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000779367702077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 47 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'LONG-TERM SURVIVAL IN WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER: INTERPLAY BETWEEN RB1 AND BRCA1/2', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, BMJ PUBLISHING GROUP, Vol. 29, pp. A146 - A147, http://dx.doi.org/10.1136/ijgc-2019-ESGO.208
,2019, 'Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 98 - 99, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 20 - 21, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'The genomic landscape of high-grade serous ovarian cancer in long-term survivors', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-2722
,2018, 'Identification of 17 Candidate Ovarian Cancer Genes from Whole-exome Sequencing in 15 Ovarian Cancer Families', in AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, WILEY, Vol. 58, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443678800043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.5583
,2018, 'Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, Vol. 78, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-225
,2017, 'Mucinous Ovarian Cancers of Uncertain Primary (MO-CUP) - Does the Site of Origin Really Matter?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 73 - 73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Association between menopausal estrogen-only therapy and ovarian carcinoma risk', in Obstetrical and Gynecological Survey, Vol. 71, pp. 470 - 471, http://dx.doi.org/10.1097/01.ogx.0000489579.62561.b8
,, 2016, 'Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer—BRCA: Challenges and Opportunities: Presented by the Hereditary Breast and Ovarian Cancer Foundation in collaboration with the Program in Cancer Genetics, McGill University; Centre Mont-Royal, Montreal, QC; 10–13 May 2016.', in Current oncology (Toronto, Ont.), Vol. 23, pp. e284 - e319
2016, 'A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, Vol. 76, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016, http://dx.doi.org/10.1158/1538-7445.AM2016-797
,2015, 'Investigation of small GTPase genes in epithelial ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, FL, Orlando, Vol. 22, presented at AACR Special Conference on Advances in Ovarian Cancer Research - Exploiting Vulnerabilities, FL, Orlando, 17 October 2015 - 20 October 2015, http://dx.doi.org/10.1158/1557-3265.OVCA15-B27
,2015, 'Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-2783
,2015, 'Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-4246
,2015, 'Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-4633
,2015, 'Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-4635
,2015, 'Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-4634
,2014, 'ENHANCED GAB2 EXPRESSION IS CHARACTERISTIC OF A CLINICALLY DISTINCT PI3K-DEPENDENT SUBTYPE OF HIGH-GRADE SEROUS AND ENDOMETRIOID OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 256 - 257, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'IDENTIFICATION OF SIX NOVEL, COMMON VARIANT GENETIC SUSCEPTIBILITY LOCI FOR INVASIVE EPITHELIAL OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'PROGNOSTIC MARKERS FOR HIGH GRADE SEROUS OVARIAN CANCER AND VALIDATION USING LARGE SCALE NANOSTRING EXPRESSION PROFILING: AN OTTA CONSORTIUM STUDY.', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 382 - 383, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, WA, Seattle, Vol. 21, presented at 10th Biennial Ovarian Cancer Research Symposium, WA, Seattle, 08 September 2014 - 09 September 2014, http://dx.doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-CTRL-1213
,2014, 'Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-946
,2014, 'Functional analysis of the 9p22 locus implicates the transcriptional regulation of BNC2 as a mechanism in ovarian cancer predisposition', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-3285
,2014, 'GWAS identifies risk variants for mucinous ovarian carcinoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 74, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-3283
,2013, 'IMMUNOMODULATORY GENE VARIANTS ARE ASSOCIATED WITH EPITHELIAL OVARIAN CANCER (EOC) RISK AND HISTOPATHOLOGIC SUBTYPE', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330379500159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Rapid RNA-based histotyping of ovarian carcinomas', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 19, http://dx.doi.org/10.1158/1078-0432.OVCA13-B14
,2013, 'The ovarian tumor tissue analysis (OTTA) consortium', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 19, http://dx.doi.org/10.1158/1078-0432.OVCA13-A27
,2013, 'Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-1352
,2013, 'Long non-coding RNAs as functional targets of germline genetic variation at ovarian cancer susceptibility loci.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-2559
,2013, 'Polymorphisms in regulatory T cell related genes and ovarian cancer survival', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-4844
,2013, 'Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-4850
,2013, 'Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-3644
,2013, 'Biomarker Based Ovarian Carcinoma Typing: A Retrospective Analysis of the OTTA Consortium', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MD, Baltimore, Vol. 93, pp. 285A - 285A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314789301516&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Biomarker Based Ovarian Carcinoma Typing: A Retrospective Analysis of the OTTA Consortium', in MODERN PATHOLOGY, NATURE PUBLISHING GROUP, MD, Baltimore, Vol. 26, pp. 285A - 285A, presented at 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MD, Baltimore, 02 March 2013 - 08 March 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314444401596&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'NF-kB Polymorphisms and Ovarian Cancer Risk', in GENETIC EPIDEMIOLOGY, WILEY-BLACKWELL, WA, Stevenson, Vol. 36, pp. 741 - 742, presented at Annual Meeting of the International-Genetic-Epidemiology-Society (IGES), WA, Stevenson, 18 October 2012 - 20 October 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309913200081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Functional effects of SNPs in non-coding RNAs at the 3q25 ovarian cancer susceptibility locus', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-2928
,2012, 'MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-2927
,2012, 'Subtype-specific ovarian cancer risk associated with SNPs in IL1A', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-2603
,2012, 'A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival', in Hereditary cancer in clinical practice, Vol. 10, pp. A27 - A27
,2012, 'Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer', in Hereditary cancer in clinical practice, Vol. 10, pp. A86 - A86, http://dx.doi.org/10.1186/1897-4287-10-s2-a86
,2011, 'Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing', in GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 121, pp. S2 - S3, http://dx.doi.org/10.1016/j.ygyno.2011.02.028
,2011, 'Functional analysis of candidate genes at ovarian cancer susceptibility loci', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-4728
,2011, 'Microarray CGH profiling predicts survival after a diagnosis of epithelial ovarian cancer and identifies novel candidate therapeutic targets', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-LB-319
,2010, 'New ovarian cancer susceptibility loci identified', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 70, http://dx.doi.org/10.1158/1538-7445.AM10-3860
,